The CRC Blueprint

My scientific approach to my own cancer – shared with you.

Early phase 1

ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer

Early phase 1 · 100 people · 1 site in United States · Recruiting now

October 20, 2026
INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases

Early phase 1 · 10 people · 1 site in United States · Recruiting now

October 20, 2026
Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer

Early phase 1 · 15 people · 1 site in China · Recruiting now

October 20, 2026
Botensilimab, Balstilimab, and SBRT in Colorectal Cancer

Early phase 1 · 15 people · 1 site in United States · Recruiting now

October 20, 2026
CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors

Early phase 1 · 36 people · 1 site in China · Recruiting now

October 20, 2026
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

Early phase 1 · 30 people · 1 site in United States · Recruiting now

October 20, 2026
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Metastasis

Early phase 1 · 10 people · 2 sites in United States · Recruiting now

October 20, 2026
Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

Early phase 1 · 120 people · 1 site in United States · Recruiting now

August 11, 2026